Amy Detweiler’s Post

View profile for Amy Detweiler, graphic

Senior Benefits Consultant at OneDigital

GLP-1 Class Drugs: To Cover or Not? GLP-1 class drugs, primarily used for the treatment of type 2 diabetes, are highly sought after, given their effectiveness in managing blood sugar levels and promoting weight loss. Coverage of these drugs has even been seen as a recruiting strategy, particularly for potential employees who may be managing diabetes. However, industry turnover rates may impact the employer’s return on investment. Register now for @OneDigital’s exclusive Transform & Engage to join this timely session from pharmacy consulting expert @Richard Lo who offers the latest perspectives and considerations for this revolutionary class of medications. Washington, D.C.: https://lnkd.in/edA4nbWN #weareonedigital #transformandengage #makeitmatter #bestworkbestlife #workplacewellbeing

Transform & Engage DC 2024 | OneDigital

Transform & Engage DC 2024 | OneDigital

onedigital.com

To view or add a comment, sign in

Explore topics